PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00078585
Recruitment Status : Completed
First Posted : March 3, 2004
Last Update Posted : September 11, 2017
Therion Biologics Corporation
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Bavarian Nordic